Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

OHSU study will evaluate vitamin D in patients with recurring prostate cancer

Nov. 16, 1999

Kotobuki presents new sulfonamide MMP inhibitors

Nov. 15, 1999

Antisense compounds from Isis target human cancer-associated mdm2

Nov. 15, 1999

Photogen teams up with Akorn to advance development of PH-10

Nov. 12, 1999

Preparation and activity of apoptosis inducers disclosed by Takara Shuzo

Nov. 12, 1999

Meiji Milk Products reveals new antiangiogenic agents

Nov. 12, 1999

Combined data from three clinical trials of ibritumomab tiuxetan confirm safety in NHL

Nov. 11, 1999

Preclinical and interim clinical data presented for CN-706 at ASTRO

Nov. 11, 1999

Etanidazole + radiosurgery for brain tumors fails to improve survival compared to radiosurgery alone

Nov. 11, 1999

Modulators of MDR in development at Nikken Chemicals

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...